Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease

There are no proven, effective therapies for polycystic kidney disease (PKD) or polycystic liver disease (PLD). We enrolled 42 patients with severe PLD resulting from autosomal dominant PKD (ADPKD) or autosomal dominant PLD (ADPLD) in a randomized, double-blind, placebo-controlled trial of octreotid...

詳細記述

保存先:
書誌詳細
主要な著者: Hogan, Marie C., Masyuk, Tetyana V., Page, Linda J., Kubly, Vickie J., Bergstralh, Eric J., Li, Xujian, Kim, Bohyun, King, Bernard F., Glockner, James, Holmes, David R., Rossetti, Sandro, Harris, Peter C., LaRusso, Nicholas F., Torres, Vicente E.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Nephrology 2010
主題:
Clinical Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2900957/
https://ncbi.nlm.nih.gov/pubmed/20431041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2009121291
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料